Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer
Diagnostic and Interventional Imaging · 2025
DOI: 10.1016/j.diii.2025.06.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostic and Interventional Imaging, 2025. Verfasst von Ghina Jardali und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, Un…. Hauptthemen laut MEDLINE: Neoplasms, Tomography, X-Ray Computed, Tumor Burden. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Association of Technical Research, French National Research Agency.
Abstract (Originalsprache)
PURPOSE: The purpose of this study was to evaluate baseline tumor burden from liquid biopsy (LB) and computed tomography (CT) as prognostic biomarkers and whether their combination refines stratification in metastatic solid cancers. MATERIALS AND METHODS: This retrospective cohort study included 1065 patients. Eligible patients underwent LB and chest-abdomen-pelvis CT examination at baseline. Radiologists outlined lesions on the largest axial slice, and total tumor volume (TTV) was approximated in three dimensions. LB Tumor fraction (TF) ≥ 10 % was considered high. To assess combined prognostic power of LB and TTV, patients were divided into three groups according to LB (circulating tumor deoxyribonucleic acid [ctDNA] detectability and TF) and each group was further divided into two subgroups using TTV thresholds determined by Youden's index. Overall survival (OS) analyses were performed using Cox proportional hazard models and Kaplan-Meier curves. RESULTS: A total of 560 patients (290 women and 270 men; median age, 61 years) with 31,314 annotated lesions were selected. The median OS was 11.28 months, and the median TTV was 96.68 cm3. The LB groups included patients with undetectable ctDNA (n = 102), patients with detectable ctDNA and low TF (n = 251), and patients with high TF (n = 207). Integrating TTV thresholds (18.7 cm3, 44.9 cm3, and 159.94 cm3) to LB groups significantly stratified the population on OS. Patients with undetectable ctDNA and TTV ≥ 18.7 cm3 had significantly shorter OS (median OS, 24.8 months) than those with TTV 35 months). CONCLUSION: Combining baseline CT tumor burden with LB could be a valuable prognostic tool for stratifying patients with metastatic solid cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, Franc…
- Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France; Guerbet Research, 93420 Villepinte, France.
- Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France.
- Department of Medical Imaging, Institut Bergonié, 33076 Bordeaux, France.
- Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France.
- Drug Development Department (DITEP), Gustave Roussy - Cancer Campus, 94805 Villejuif, France; Université Paris-Saclay, Faculté de Médecine, 94270 Le Kremlin-Bicêtre, France.
Förderung
- National Association of Technical Research
- French National Research Agency
Zitieren
APA
Jardali, G., Lawrance, L., Dawi, L., Dupont, J., Gautier, O., Kind, M., Ammari, S., Hadchiti, J., Choucair, A., Bayle, A., Cournède, P. H., Borget, I., Muller, S., Bidault, F., Balleyguier, C., Hollebecque, A., Loriot, Y., Dall-Olio, F. G., Besse, B., …, & Lassau, N. (2025). Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. Diagnostic and Interventional Imaging. https://doi.org/10.1016/j.diii.2025.06.002
Vancouver
Jardali G, Lawrance L, Dawi L, Dupont J, Gautier O, Kind M, et al. Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. Diagnostic and Interventional Imaging. 2025. doi:10.1016/j.diii.2025.06.002
BibTeX
@article{Jardali2025,
author = {Jardali, Ghina and Lawrance, Littisha and Dawi, Lama and Dupont, Jules and Gautier, Othilie and Kind, Michèle and Ammari, Samy and Hadchiti, Joya and Choucair, Aurélie and Bayle, Arnaud and Cournède, Paul-Henry and Borget, Isabelle and Muller, Serge and Bidault, François and Balleyguier, Corinne and Hollebecque, Antoine and Loriot, Yohann and Dall-Olio, Filippo Gustavo and Besse, Benjamin and Lacroix, Ludovic and Rouleau, Etienne and Bône, Alexandre and André, Fabrice and Massard, Christophe and Barlesi, Fabrice and Italiano, Antoine and Lassau, Nathalie},
title = {Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer},
journal = {Diagnostic and Interventional Imaging},
year = {2025},
doi = {10.1016/j.diii.2025.06.002}
}
EUVIMED